학술논문
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
Document Type
Article
Author
Lazaridis, L.; Agkatsev, S.; Schmidt, T.; Oster, C.; Feldheim, J.; Kleinschnitz, C.; Kebir, S.; Glas, M.; Blau, T.; Sure, U.; Keyvani, K.; Stuschke, M.; Herrmann, K.; Deuschl, C.; Scheffler, B.; Bumes, E.; Hau, P.; Cäcilia Spille, D.; Stummer, W.; Schulz, T.; Kessler, A.F.; Heider, S.; Seidel, C.; Grauer, O.; Herrlinger, U.; Breuer, S.; Hattingen, E.
Source
In: Neuro-Oncology Advances . (Neuro-Oncology Advances, 1 January 2022, 4(1))
Subject
Language
English
ISSN
26322498